Clinical Trial

Risk Factors of Medistinal Metastasis in Endoscopic Staging of Lung Cancer

Unknown
View on ClinicalTrials.gov →
Summary
The purpose of this study is to investigate risk factors for mediastinal lymph node metastasis in potentially operable non-small cell lung cancer in order to find indications for endoscopic mediastinal staging. Chest CT, integrated PET/CT, and endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) +/- endoscopic ultrasound with bronchoscope-guided fine needle aspiration (EUS-B-FNA) are performed for mediastinal staging. CT and PET/CT findings, histologic types and other risk factors will be analyzed. The investigators develop the prediction method for mediastinal metastasis.
Protocol Amendment History 1 change
critical Trial status changed: Active, Not Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT02991924
Lead Sponsor National Cancer Center, Korea
Collaborators: Seoul National University Hospital, Samsung Medical Center, Asan Medical Center, Seoul National University Bundang Hospital
Conditions Non Small Cell Lung Cancer
Enrollment 600 participants
Start Date 2016-07
Primary Completion 2019-12 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-04-04